Funding News

Thena Capital TCX-1 LP has joined the cap table of Zonova Technologies Ltd, taking a holding of 201,005 Preference shares. This change was recorded in the company's latest confirmation statement for t...

Lentitek Ltd is an Edinburgh-based biotechnology company founded in 2019. The firm develops proprietary technology to enhance the quality and yield of lentiviral vectors used in advanced gene and cell...

Gusto Family Investment Company Ltd has joined the cap table of Oxford Molecular Biosensors Limited, acquiring 125,053 ordinary shares. This entry is the largest change recorded in the company's lates...

Emstopa Limited is a Sandwich-based biotechnology company founded in 2017. The firm develops a humanised antibody fragment designed to block tissue-type plasminogen activator (tPA). This technology ai...

Development of the miONCO-Dx screening tool has been bolstered by an estimated £1.5m investment into Xgenera Ltd. This blood-based multi-cancer early detection system is designed for use in the health...

Epsilogen Ltd, a London-based developer of immunoglobulin E antibody therapeutics for cancer treatment, has recorded stake increases from three existing institutional investors. Founded in 2016, the c...

Developing a new generation of herbicides to address the global threat of weed resistance is the focus of Moa Technology, a biotechnology company spun out of Oxford University. It utilizes artificial ...

MEGUMI LTD has exited the cap table of Llusern Scientific Ltd, according to the company's latest confirmation statement. The investor disposed of its entire holding of 646 Ordinary shares during the p...

A round of approximately £106.2k has been obtained by Cardiff-based Llusern Scientific to advance its portable molecular diagnostic platform. This new injection of capital brings the total funding rai...

XFACTOR 2022, L.P. has joined the Boobybiome Ltd cap table as a new shareholder, according to the company's latest confirmation statement for the period ending 30 June 2026. The investor now holds 12,...

Engineering natural, fungi-derived compounds to assist the brain in self-regulation is the core focus of State Mode Limited. The Ascot-based startup develops these substances to restore focus, resilie...

Edinburgh-based Prothea Technologies has seen its primary institutional investors increase their positions by 82 percent. Founded in 2021, the company develops an AI-driven platform that combines lung...

Good Dog Food Limited, trading as Meatly, is a London based company founded in 2021. It develops cultivated meat dog treats using cellular agriculture technology and sells them to pet owners through r...

Duke Street Bio Limited, a London-based precision medicine biotechnology company, has updated its cap table following its latest confirmation statement for the period ending 1 July 2026. Founded in 20...

High-performance biopolymers are the focus of a new £158.5k funding round for Demeter Bio Limited. Based in London, the biotechnology firm develops sustainable materials from renewable sources to offe...

Developing new therapeutics for migraine and other headache disorders is the primary focus of Altrincham-based Slate Medicines Uk Limited. The company concentrates on research and experimental develop...

A London-based developer of medical treatments, Ventrazym Ltd, is creating a non-animal derived digestive enzyme blend called VentraZym. The company recently secured £81.8k in a funding round that pla...

Ultra-rapid diagnostic technology that identifies infectious diseases from saliva samples within 60 seconds is being developed by Accelerated Diagnostics Limited. The Harlow-based company recently sec...

Tilebio is developing AI pathology foundation models designed to learn a universal visual language of tissue from unlabelled medical images. The Glasgow-based company recently raised an estimated £400...

An estimated £308.1k has been raised by Pnds Medical Ltd in a funding round that values the London-based company at approximately £2.8m. The business operates in the biotechnology field, focusing on r...

Developing small-molecule degraders to target central nervous system neurodegenerative diseases is the core focus of Trimtech Therapeutics, which has recently secured an estimated £7.5m in seed fundin...

An estimated £250k seed round has been secured by Implexis Ltd to support its proprietary platform. Based in London, the company aims to accelerate drug formulation development, reduce time-to-market,...

Providing high-throughput and cost-effective testing for clinical laboratories, Ifast Diagnostics Limited has secured an estimated £3m seed funding round. The company develops a rapid antimicrobial su...

An estimated £1.1m has been raised by Septest Limited to support the development of infection-diagnostic tools, including the TRISEP multi-marker test. The investment values the Potters Bar-based busi...

A Series A funding round of £23.1m has been secured by Cardiff-based Draig Therapeutics to advance its clinical-stage treatments for neuropsychiatric diseases. The company focuses on restoring brain h...

Liquid-biopsy assays that analyze the biochemistry of the endothelial glycocalyx are being developed by Dimension Biotechnologies to assess microvascular health and disease. The Bristol-based company ...

Predicting cancer patient response to immunotherapy is the focus of Curenetics Ltd, a London-based software development firm that has just secured £161.1k in new funding. This capital injection values...

Targeting proteins often considered undruggable, Revolver Therapeutics Limited has raised £572.6k in its latest funding round. The Bath-based company focuses on oncology by developing peptide-based in...

Persica Pharmaceuticals, a clinical-stage biotechnology company, has secured an estimated £2m in new funding at a post-money valuation of £107.2m. The Canterbury-based firm is developing PP353, a pate...

Biotechnology research and experimental development specialist Imphatec Ltd has secured an estimated £205k in a recent funding round. Based in Liss, the company focuses on the manufacture of basic pha...